Treatment of overactive bladder in patients with symptoms of:
– Urinary frequency.
– Urinary urgency.
– Urge urinary incontinence.
One URICONTROL tablet (2 mg) twice daily. A lower dose of half URICONTROL tablet (1 mg)
twice daily is recommended in patients who experience adverse effects or receive drugs that
inhibit the cytochrome P450 enzyme system.
Hypersensitivity to any of drug components, urinary retention and uncontrolled narrow-angle glaucoma.
In patients with hepatic impairment or severe renal impairment, the dose should be reduced to half
URICONTROL tablet (1 mg) twice daily. Due to possibility of vision blurring the patient should be
cautioned against driving or operating machinery.
* Pregnancy and Lactation:
As with other tolterodine-containing preparations, the drug should not be used during pregnancy and
* Keep at temp. (15-30 degrees C), away from light & moisture.